Analyst Matt Miksic works at CREDIT SUISSE and is focused on the Healthcare sector with 474 price targets and ratings documented since 2012 spanning on 18 stocks. Analyst's average stock valuation to be materialised ratio is 61.92% with an average time for price targets to be met of 388.28 days.
Most recent stock forecast was given on MDT, Medtronic plc at 25-Nov-2022.
Matt Miksic best performing recommendations are on ORGO (ORGANOGENESIS HOLDINGS INC).
The best stock recommendation documented was for ORGO (ORGANOGENESIS HOLDINGS INC) at 3/12/2021. The price target of $21 was fulfilled within 10 days with a profit of $3.28 (18.51%) receiving and performance score of 18.51.
Average potential price target upside